Results 101 to 110 of about 18,186,442 (245)

A general-purpose framework for chemical reaction representation with atomic correspondence and flexible condition adaptation

open access: yesJournal of Cheminformatics
Motivation Organic synthesis is fundamental to the chemical industry, particularly in domains such as pharmaceutical development. While artificial intelligence offers powerful tools for modeling chemical reactions, current approaches are primarily ...
Kaipeng Zeng   +5 more
doaj   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Chemical Graph-Based Transformer Models for Yield Prediction of High-Throughput Cross-Coupling Reaction Datasets

open access: yes
The chemical reaction yield is an important factor to determine the reaction conditions. Recently, many data-driven models for yield prediction using high-throughput experimentation datasets have been reported.
Miyao, Tomoyuki   +4 more
core   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Reaction kinetics for chemical engineers

open access: yes, 1989
Reaction Kinetics for Chemical ...
Walas, Stanley M.
core  

Chemical Reaction Network Control Systems for Agent-Based Foraging Tasks [PDF]

open access: yes, 2015
Chemical reaction networks are an unconventional computing medium that could benefit from the ability to form basic control systems. In this work, we demonstrate the functionality of a chemical control system by evaluating classic genetic algorithm ...
Moles, Joshua Stephen
core   +1 more source

Artificial Intelligence in Numerical Modeling of Silver Nanoparticles Prepared in Montmorillonite Interlayer Space

open access: yesJournal of Chemistry, 2013
Artificial neural network (ANN) models have the capacity to eliminate the need for expensive experimental investigation in various areas of manufacturing processes, including the casting methods.
Parvaneh Shabanzadeh   +3 more
doaj   +1 more source

Modeling chemical reaction networks on the Pontryagin bundle with the Hamilton-Pontryagin approach

open access: yesIFAC-PapersOnLine, 2015
Abstract The Lagrange-d'Alembert-Pontryagin principle is a versatile approach to model dynamical systems including resistive forces from the Lagrangian view. We show in this work, how this method can be applied to open stoichiometric reaction networks.
Lindhorst, H., Waldherr, S.
openaire   +2 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy